Roivant Sciences (ROIV): are the analysts right?

Roivant Sciences · Health Care · ref. ETF XLV · 56 calls · price $34.41
What the company does: Roivant Sciences découvre et développe médicaments et technologies pour indications autoimmunes et autres.
📈 1-year price
$36.31+234.3% over range
Jul 8, 25low $10.86 · high $36.31Jul 7, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
100% recommend buying · 5 analysts

🎯 Analyst price target on ROIV

High target · 2 analysts$42+22.1%
Median target · 5 analysts$40+16.2%
Low target · 1 analyst$34-1.2%
Current price$34.41

🗳️ The analyst consensus

Analyst breakdown · 5 (6 months)
Strong Buy0%
Buy100%
Hold0%
Sell0%
Strong Sell0%

✅ Historical analyst reliability on ROIV

Most reliable analysts on ROIV (% profitable · 365j · ≥2 calls)
Guggenheim 100% +22.4% 2
Piper Sandler 100% +0.8% 2
Cantor Fitzgerald 78% +21.8% 9
HC Wainwright & Co. 75% +66.4% 12
Deutsche Bank 50% +2.0% 2
Goldman Sachs 0% -15.0% 2

📊 What $1,000 invested in Roivant Sciences would be worth

In short — $1,000 invested in Roivant Sciences 10 years ago would be worth $3,568 today, i.e. +24%/yr on average. Best year: 2025 (+88%), worst: 2022 (-21%). Price performance, excluding dividends.

If I'd invested $1,000 in Roivant Sciences

InvestmentWorth todayGain
1 years ago$3,027+203%
3 years ago$4,429+343%
5 years ago$3,480+248%
since inception (2020)$3,568+257%

Return by year (Roivant Sciences)

YearReturn$1,000 invested at year start
2026 (YTD)+61%$1,614 (+61%)
2025+88%$3,027 (+203%)
2024+4%$3,151 (+215%)
2023+41%$4,429 (+343%)
2022-21%$3,511 (+251%)
2021-1%$3,480 (+248%)
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.

🔎 Detailed analyses

👥 Analysts & forecasts📊 Returns & performance
📈 Fundamentals, technical momentum and live news will show here on the final site (loaded live from the same origin as the API).

📋 All analyst calls on ROIV

Guggenheim
May 26, 26
▲ Buy · 🎯$36
Price at call : $29.67 — upside +21%
Today : $34.41 — upside +5%
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : May 26, 27
Citigroup
May 21, 26
▲ Buy · 🎯$42
Price at call : $29.96 — upside +40%
Today : $34.41 — upside +22%
🎯 on ROIV : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : May 21, 27
TD Cowen
May 21, 26
▲ Buy · 🎯$41
Price at call : $29.96 — upside +37%
Today : $34.41 — upside +19%
🎯 on ROIV : no call matured yet · 📊 on Health : 61.9% · +26.8% (21 calls)
in progress (365j)
matures : May 21, 27
▲ Buy · 🎯$34
Price at call : $30.88 — upside +10%
Today : $34.41 — upside -1%
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : May 21, 27
Piper Sandler
Apr 16, 26
▲ Overweight · 🎯$40
Price at call : $29.83 — upside +34%
Today : $34.41 — upside +16%
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
in progress (365j)
matures : Apr 16, 27
▲ Buy · 🎯$34
Price at call : $29.52 — upside +15%
Today : $34.41 — upside -1%
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Mar 4, 27
Citigroup
Feb 10, 26
▲ Buy · 🎯$35
Price at call : $26.8 — upside +31%
Today : $34.41 — upside +2%
🎯 on ROIV : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Feb 10, 27
▲ Buy · 🎯$33
Price at call : $27.35 — upside +21%
Today : $34.41 — upside -4%
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Feb 10, 27
Guggenheim
Feb 9, 26
▲ Buy · 🎯$30
Price at call : $27.35 — upside +10%
Today : $34.41 — upside -13%
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Feb 9, 27
▲ Outperform · 🎯$32
Price at call : $22.94 — upside +39%
Today : $34.41 — upside -7%
🎯 on ROIV : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Dec 15, 26
Goldman Sachs
Dec 15, 25
▲ Buy · 🎯$33
Price at call : $22.94 — upside +44%
Today : $34.41 — upside -4%
🎯 on ROIV : 0% (2 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Dec 15, 26
▲ Buy · 🎯$26
Price at call : $21.9 — upside +19%
Today : $34.41 — upside -24%
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Dec 12, 26
Citigroup
Nov 11, 25
▲ Buy · 🎯$26
Price at call : $21.32 — upside +22%
Today : $34.41 — upside -24%
🎯 on ROIV : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Nov 11, 26
Citigroup
Oct 29, 25
▲ Buy · 🎯$25
Price at call : $19.58 — upside +28%
Today : $34.41 — upside -27%
🎯 on ROIV : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Oct 29, 26
Goldman Sachs
Sep 18, 25
▲ Buy · 🎯$24
Price at call : $15.04 — upside +60%
Today : $34.41 — upside -30%
🎯 on ROIV : 0% (2 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
in progress (365j)
matures : Sep 18, 26
Jefferies
Sep 18, 25
▲ Buy · 🎯$20
Price at call : $15.04 — upside +33%
Today : $34.41 — upside -42%
🎯 on ROIV : no call matured yet · 📊 on Health : 48% · +9.7% (98 calls)
in progress (365j)
matures : Sep 18, 26
JP Morgan
Sep 18, 25
▲ Overweight · 🎯$20
Price at call : $15.09 — upside +33%
Today : $34.41 — upside -42%
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
in progress (365j)
matures : Sep 18, 26
Guggenheim
Sep 18, 25
▲ Buy · 🎯$21
Price at call : $15.09 — upside +39%
Today : $34.41 — upside -39%
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
in progress (365j)
matures : Sep 18, 26
▲ Outperform · 🎯$22
Price at call : $15.09 — upside +46%
Today : $34.41 — upside -36%
🎯 on ROIV : no call matured yet · 📊 on Health : 44.4% · -4.7% (9 calls)
in progress (365j)
matures : Sep 18, 26
■ Neutral neutral · not a buy · 🎯$16.5
Price at call : $15.09 — gap to target +9%
Today : $34.41 — gap to target -52%
🎯 on ROIV : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Sep 18, 26
▲ Buy · 🎯$20
Price at call : $15.09 — upside +33%
Today : $34.41 — upside -42%
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
in progress (365j)
matures : Sep 18, 26
Citigroup
Sep 2, 25
▲ Buy · 🎯$16
Price at call : $12.39 — upside +29%
Today : $34.41 — upside -54%
🎯 on ROIV : no call matured yet · 📊 on Health : 56.8% · +16.5% (118 calls)
in progress (365j)
matures : Sep 2, 26
▲ Buy · 🎯$18
Price at call : $11.44 — upside +57%
Today : $34.41 — upside -48%
Expected +57% · Actual +175% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+174.7%
stock +175% · XLV +12%
▲ Buy · 🎯$18
Price at call : $10.62 — upside +69%
Today : $34.41 — upside -48%
Expected +69% · Actual +181% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+181.4%
stock +181% · XLV +15%
▲ Buy · 🎯$18
Price at call : $10.42 — upside +73%
Today : $34.41 — upside -48%
Expected +73% · Actual +180% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+179.8%
stock +180% · XLV +8%
▲ Buy · 🎯$18
Price at call : $10.44 — upside +72%
Today : $34.41 — upside -48%
Expected +72% · Actual +156% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+156.2%
stock +156% · XLV +7%
▲ Buy · 🎯$18
Price at call : $11.64 — upside +55%
Today : $34.41 — upside -48%
Expected +55% · Actual +74% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+74.3%
stock +74% · XLV +5%
▲ Overweight
Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+24.8%
stock +25% · XLV -12%
▲ Buy · 🎯$18
Price at call : $11.92 — upside +51%
Today : $34.41 — upside -48%
Expected +51% · Actual +26% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+26.2%
stock +26% · XLV -12%
■ Neutral neutral · not a buy · 🎯$12.5
Price at call : $12.38 — gap to target +1%
Today : $34.41 — gap to target -64%
🎯 on ROIV : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Sep 11, 25
▲ Buy · 🎯$18
Price at call : $12.38 — upside +45%
Today : $34.41 — upside -48%
Expected +45% · Actual +16% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+16.4%
stock +16% · XLV -10%
▲ Overweight
Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+7.8%
stock +8% · XLV -11%
▲ Buy · 🎯$18
Price at call : $11.49 — upside +57%
Today : $34.41 — upside -48%
Expected +57% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+2.4%
stock +2% · XLV -11%
Piper Sandler
Jul 10, 24
▲ Overweight · 🎯$22
Price at call : $11.24 — upside +96%
Today : $34.41 — upside -36%
Expected +96% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
+1.1%
stock +1% · XLV -8%
▲ Overweight
Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+6.0%
stock +6% · XLV -9%
▲ Buy · 🎯$18
Price at call : $10.36 — upside +74%
Today : $34.41 — upside -48%
Expected +74% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
+7.8%
stock +8% · XLV -8%
▲ Buy · 🎯$18
Price at call : $10.6 — upside +70%
Today : $34.41 — upside -48%
Expected +70% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-1.7%
stock -2% · XLV -3%
▲ Buy · 🎯$18
Price at call : $11.51 — upside +56%
Today : $34.41 — upside -48%
Expected +56% · Actual -18% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 0% (2 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-17.8%
stock -18% · XLV -5%
▲ Buy · 🎯$18
Price at call : $11.51 — upside +56%
Today : $34.41 — upside -48%
Expected +56% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-13.0%
stock -13% · XLV -1%
▲ Buy · 🎯$15
Price at call : $11.51 — upside +30%
Today : $34.41 — upside -56%
Expected +30% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 50% (2 calls matureds) · 📊 on Health : 51.3% · +8.7% (76 calls)
-13.0%
stock -13% · XLV -1%
▲ Buy · 🎯$23
Price at call : $10.08 — upside +128%
Today : $34.41 — upside -33%
Expected +128% · Actual +4% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 62% · +8.5% (92 calls)
+3.6%
stock +4% · XLV -1%
▲ Outperform · 🎯$17
Price at call : $11.45 — upside +48%
Today : $34.41 — upside -51%
Expected +48% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 0% (1 call matured) · 📊 on Health : 46.2% · +2.9% (13 calls)
-7.8%
stock -8% · XLV -0%
▲ Buy · 🎯$17
Price at call : $11.45 — upside +48%
Today : $34.41 — upside -51%
Expected +48% · Actual -8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 75% (12 calls matureds) · 📊 on Health : 67.2% · +22.3% (201 calls)
-7.8%
stock -8% · XLV -0%
▲ Overweight · 🎯$20
Price at call : $11.44 — upside +75%
Today : $34.41 — upside -42%
Expected +75% · Actual +1% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 41.4% · +4.5% (116 calls)
+0.6%
stock +1% · XLV -1%
■ Neutral neutral · not a buy · 🎯$12
Price at call : $10.86 — gap to target +10%
Today : $34.41 — gap to target -65%
🎯 on ROIV : no call matured yet · 📊 on Health : 61.4% · +19.8% (83 calls)
in progress (365j)
matures : Jan 1, 25
Deutsche Bank
Dec 12, 23
▲ Buy · 🎯$14
Price at call : $10.35 — upside +35%
Today : $34.41 — upside -59%
Expected +35% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 50% (2 calls matureds) · 📊 on Health : 51.3% · +8.7% (76 calls)
+17.0%
stock +17% · XLV +6%
Guggenheim
Nov 15, 23
▲ Buy · 🎯$16
Price at call : $9.02 — upside +77%
Today : $34.41 — upside -54%
Expected +77% · Actual +24% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+24.2%
stock +24% · XLV +10%
JP Morgan
Nov 14, 23
▲ Overweight · 🎯$15
Price at call : $9.07 — upside +65%
Today : $34.41 — upside -56%
Expected +65% · Actual +28% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (1 call matured) · 📊 on Health : 48.4% · +4.8% (126 calls)
+28.3%
stock +28% · XLV +13%
Guggenheim
Oct 17, 23
▲ Buy · 🎯$17
Price at call : $9.87 — upside +72%
Today : $34.41 — upside -51%
Expected +72% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 100% (2 calls matureds) · 📊 on Health : 63.4% · +15.5% (41 calls)
+20.7%
stock +21% · XLV +17%
Goldman Sachs
Sep 27, 23
▲ Buy · 🎯$16
Price at call : $13.19 — upside +21%
Today : $34.41 — upside -54%
Expected +21% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 0% (2 calls matureds) · 📊 on Health : 52.2% · +7.8% (90 calls)
-12.3%
stock -12% · XLV +19%
▲ Overweight · 🎯$15
Price at call : $11.12 — upside +35%
Today : $34.41 — upside -56%
Expected +35% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+8.4%
stock +8% · XLV +18%
▲ Overweight · 🎯$15
Price at call : $11.75 — upside +28%
Today : $34.41 — upside -56%
Expected +28% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
0.0%
stock +0% · XLV +18%
▲ Overweight · 🎯$15
Price at call : $11.57 — upside +30%
Today : $34.41 — upside -56%
Expected +30% · Actual +6% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+5.7%
stock +6% · XLV +18%
▲ Overweight · 🎯$15
Price at call : $11.71 — upside +28%
Today : $34.41 — upside -56%
Expected +28% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
-0.3%
stock -0% · XLV +16%
▲ Overweight · 🎯$15
Price at call : $9.79 — upside +53%
Today : $34.41 — upside -56%
Expected +53% · Actual +10% · Reason (≥ +15%) : ✗ No
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+10.3%
stock +10% · XLV +11%
▲ Overweight · 🎯$15
Price at call : $3.69 — upside +307%
Today : $34.41 — upside -56%
Expected +307% · Actual +134% · Reason (≥ +15%) : ✓ Yes
🎯 on ROIV : 78% (9 calls matureds) · 📊 on Health : 58.8% · +20.2% (97 calls)
+133.6%
stock +134% · XLV +3%
JPI AI Analyst AI assistant · JPI Invest
Answers based on the tool’s data · not financial advice · full version (free)